Global Point of Care or Rapid Testing Report Thumbnail

Global Point of Care or Rapid Testing Market by Type (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others), By Application (Clinics, Hospitals, Laboratory, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: MDC-11307
  • Author: Up Market Research
  • Rating: 4.9
  • Total Reviews: 95
  • No. Of Pages: 228
  • Format:
  • Pub. Date: 2021-04-04
  • Share:

Up Market Research published a new report titled “Point of Care or Rapid Testing Market research report which is segmented by Types (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others), By Applications (Clinics, Hospitals, Laboratory, Others), By Players/Companies Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, ARKRAY, Nova Biomedical, Trividia Health, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Sinocare, Wondfo, Yuwell, Runbio, KHB, Wuhan EasyDiagnosis Biomedicine, DAAN GENE”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.


Report Scope

Report AttributesReport Details
Report TitlePoint of Care or Rapid Testing Market Research Report
By TypeBlood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others
By ApplicationClinics, Hospitals, Laboratory, Others
By CompaniesRoche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, ARKRAY, Nova Biomedical, Trividia Health, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Sinocare, Wondfo, Yuwell, Runbio, KHB, Wuhan EasyDiagnosis Biomedicine, DAAN GENE
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages228
Number of Tables & Figures160
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Point of Care or Rapid Testing Industry Outlook

Global Point of Care or Rapid Testing Market Report Segments:

The market is segmented by Type Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others and By Application Clinics, Hospitals, Laboratory, Others.


Some of the companies that are profiled in this report are:

  1. Roche
  2. Abbott
  3. Johnson & Johnson
  4. Siemens Healthcare
  5. Danaher
  6. Ascensia
  7. Bio-Rad Laboratories
  8. BioMerieux
  9. ARKRAY
  10. Nova Biomedical
  11. Trividia Health
  12. Quidel
  13. Accriva
  14. OraSure Technologies
  15. Helena Laboratories
  16. A. Menarini Diagnostics
  17. Abaxis (Zoetis)
  18. Ortho Clinical Diagnostics
  19. Phamatech
  20. Chembio Diagnostics
  21. Sinocare
  22. Wondfo
  23. Yuwell
  24. Runbio
  25. KHB
  26. Wuhan EasyDiagnosis Biomedicine
  27. DAAN GENE

Point of Care or Rapid Testing Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Point of Care or Rapid Testing Market

Overview of the regional outlook of the Point of Care or Rapid Testing Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Point of Care or Rapid Testing Market Overview

Highlights of The Point of Care or Rapid Testing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Point of Care or Rapid Testing Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. Blood Glucose Testing

                2. Infectious Diseases Testing

                3. Cardiac Markers Testing

                4. Coagulation Testing

                5. Pregnancy and Fertility Testing

                6. Blood Gas/Electrolytes Testing

                7. Urinalysis Testing

                8. Others

       7. By Application:

                1. Clinics

                2. Hospitals

                3. Laboratory

                4. Others

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Point of Care or Rapid Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Point of Care or Rapid Testing Market Statistics

Reasons to Purchase the Point of Care or Rapid Testing Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point of Care or Rapid Testing Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Point of Care or Rapid Testing Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Point of Care or Rapid Testing Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Point of Care or Rapid Testing Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Point of Care or Rapid Testing Market Size & Forecast, 2018-2028 
      4.5.1 Point of Care or Rapid Testing Market Size and Y-o-Y Growth 
      4.5.2 Point of Care or Rapid Testing Market Absolute $ Opportunity 


Chapter 5 Global Point of Care or Rapid Testing Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Point of Care or Rapid Testing Market Size Forecast by Type
      5.2.1 Blood Glucose Testing
      5.2.2 Infectious Diseases Testing
      5.2.3 Cardiac Markers Testing
      5.2.4 Coagulation Testing
      5.2.5 Pregnancy and Fertility Testing
      5.2.6 Blood Gas/Electrolytes Testing
      5.2.7 Urinalysis Testing
      5.2.8 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Point of Care or Rapid Testing Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Point of Care or Rapid Testing Market Size Forecast by Applications
      6.2.1 Clinics
      6.2.2 Hospitals
      6.2.3 Laboratory
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Point of Care or Rapid Testing Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Point of Care or Rapid Testing Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Point of Care or Rapid Testing Analysis and Forecast
   9.1 Introduction
   9.2 North America Point of Care or Rapid Testing Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Point of Care or Rapid Testing Market Size Forecast by Type
      9.6.1 Blood Glucose Testing
      9.6.2 Infectious Diseases Testing
      9.6.3 Cardiac Markers Testing
      9.6.4 Coagulation Testing
      9.6.5 Pregnancy and Fertility Testing
      9.6.6 Blood Gas/Electrolytes Testing
      9.6.7 Urinalysis Testing
      9.6.8 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Point of Care or Rapid Testing Market Size Forecast by Applications
      9.10.1 Clinics
      9.10.2 Hospitals
      9.10.3 Laboratory
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Point of Care or Rapid Testing Analysis and Forecast
   10.1 Introduction
   10.2 Europe Point of Care or Rapid Testing Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Point of Care or Rapid Testing Market Size Forecast by Type
      10.6.1 Blood Glucose Testing
      10.6.2 Infectious Diseases Testing
      10.6.3 Cardiac Markers Testing
      10.6.4 Coagulation Testing
      10.6.5 Pregnancy and Fertility Testing
      10.6.6 Blood Gas/Electrolytes Testing
      10.6.7 Urinalysis Testing
      10.6.8 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Point of Care or Rapid Testing Market Size Forecast by Applications
      10.10.1 Clinics
      10.10.2 Hospitals
      10.10.3 Laboratory
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Point of Care or Rapid Testing Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Point of Care or Rapid Testing Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Point of Care or Rapid Testing Market Size Forecast by Type
      11.6.1 Blood Glucose Testing
      11.6.2 Infectious Diseases Testing
      11.6.3 Cardiac Markers Testing
      11.6.4 Coagulation Testing
      11.6.5 Pregnancy and Fertility Testing
      11.6.6 Blood Gas/Electrolytes Testing
      11.6.7 Urinalysis Testing
      11.6.8 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Point of Care or Rapid Testing Market Size Forecast by Applications
      11.10.1 Clinics
      11.10.2 Hospitals
      11.10.3 Laboratory
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Point of Care or Rapid Testing Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Point of Care or Rapid Testing Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Point of Care or Rapid Testing Market Size Forecast by Type
      12.6.1 Blood Glucose Testing
      12.6.2 Infectious Diseases Testing
      12.6.3 Cardiac Markers Testing
      12.6.4 Coagulation Testing
      12.6.5 Pregnancy and Fertility Testing
      12.6.6 Blood Gas/Electrolytes Testing
      12.6.7 Urinalysis Testing
      12.6.8 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Point of Care or Rapid Testing Market Size Forecast by Applications
      12.10.1 Clinics
      12.10.2 Hospitals
      12.10.3 Laboratory
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Point of Care or Rapid Testing Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Point of Care or Rapid Testing Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Point of Care or Rapid Testing Market Size Forecast by Type
      13.6.1 Blood Glucose Testing
      13.6.2 Infectious Diseases Testing
      13.6.3 Cardiac Markers Testing
      13.6.4 Coagulation Testing
      13.6.5 Pregnancy and Fertility Testing
      13.6.6 Blood Gas/Electrolytes Testing
      13.6.7 Urinalysis Testing
      13.6.8 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Point of Care or Rapid Testing Market Size Forecast by Applications
      13.10.1 Clinics
      13.10.2 Hospitals
      13.10.3 Laboratory
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Point of Care or Rapid Testing Market: Competitive Dashboard
   14.2 Global Point of Care or Rapid Testing Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Roche
      14.3.2 Abbott
      14.3.3 Johnson & Johnson
      14.3.4 Siemens Healthcare
      14.3.5 Danaher
      14.3.6 Ascensia
      14.3.7 Bio-Rad Laboratories
      14.3.8 BioMerieux
      14.3.9 ARKRAY
      14.3.10 Nova Biomedical
      14.3.11 Trividia Health
      14.3.12 Quidel
      14.3.13 Accriva
      14.3.14 OraSure Technologies
      14.3.15 Helena Laboratories
      14.3.16 A. Menarini Diagnostics
      14.3.17 Abaxis (Zoetis)
      14.3.18 Ortho Clinical Diagnostics
      14.3.19 Phamatech
      14.3.20 Chembio Diagnostics
      14.3.21 Sinocare
      14.3.22 Wondfo
      14.3.23 Yuwell
      14.3.24 Runbio
      14.3.25 KHB
      14.3.26 Wuhan EasyDiagnosis Biomedicine
      14.3.27 DAAN GENE
Segments Covered in the Report
The global Point of Care or Rapid Testing market has been segmented based on

By Types
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Urinalysis Testing
  • Others
By Applications
  • Clinics
  • Hospitals
  • Laboratory
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Roche
  • Abbott
  • Johnson & Johnson
  • Siemens Healthcare
  • Danaher
  • Ascensia
  • Bio-Rad Laboratories
  • BioMerieux
  • ARKRAY
  • Nova Biomedical
  • Trividia Health
  • Quidel
  • Accriva
  • OraSure Technologies
  • Helena Laboratories
  • A. Menarini Diagnostics
  • Abaxis (Zoetis)
  • Ortho Clinical Diagnostics
  • Phamatech
  • Chembio Diagnostics
  • Sinocare
  • Wondfo
  • Yuwell
  • Runbio
  • KHB
  • Wuhan EasyDiagnosis Biomedicine
  • DAAN GENE

Buy Report